These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13739160)

  • 1. Oestrogenic substances contained in the fatty tissue of a mammary gland affected by carcinoma, compared with the morphological changes in its parenchyma.
    RAICHEV R; ALEXANDROV K
    Neoplasma; 1961; 8():247-52. PubMed ID: 13739160
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas.
    Muñoz-de-Toro M; Durando M; Beldoménico PM; Beldoménico HR; Kass L; García SR; Luque EH
    Breast Cancer Res; 2006; 8(4):R47. PubMed ID: 16859517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estrogens, progesterones and the mammary gland].
    Heikinheimo O
    Duodecim; 2005; 121(5):525-32. PubMed ID: 15839154
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.
    Platet N; Cathiard AM; Gleizes M; Garcia M
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):55-67. PubMed ID: 15207254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progesterone and breast cancer].
    Mansueto G; Mistretta V; Angeletti F; Trento LK; Angelozzi D; Bracaglia M; Pagliarella MR; Di Muccio L
    Recenti Prog Med; 2006; 97(7-8):376-80. PubMed ID: 16913172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
    Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
    Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of iron content of mouse mammary gland to estrogenic factors.
    RAWLINSON HE
    Proc Can Cancer Conf; 1957; 2():242-7. PubMed ID: 13437172
    [No Abstract]   [Full Text] [Related]  

  • 8. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral estrogen production in breast carcinoma: significance of aromatase.
    Suzuki T; Miki Y; Ohuchi N; Sasano H
    Breast Cancer; 2008; 15(4):270-7. PubMed ID: 18622573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy.
    Nicholson RI; Staka C; Boyns F; Hutcheson IR; Gee JM
    Endocr Relat Cancer; 2004 Dec; 11(4):623-41. PubMed ID: 15613443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids, carcinogenesis, and cancer progression.
    Castagnetta L; Granata OM; Cocciadiferro L; Saetta A; Polito L; Bronte G; Rizzo S; Campisi I; Agostara B; Carruba G
    Ann N Y Acad Sci; 2004 Dec; 1028():233-46. PubMed ID: 15650249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
    Soriano Z; Pardee JD
    Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors.
    Li H; Cherukuri P; Li N; Cowling V; Spinella M; Cole M; Godwin AK; Wells W; DiRenzo J
    Cancer Res; 2007 Jan; 67(2):501-10. PubMed ID: 17234757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dual effects of androgens on mammary gland].
    Brettes JP; Mathelin C
    Bull Cancer; 2008 May; 95(5):495-502. PubMed ID: 18541513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
    J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroids and receptors in canine mammary cancer.
    Illera JC; Pérez-Alenza MD; Nieto A; Jiménez MA; Silvan G; Dunner S; Peña L
    Steroids; 2006 Jul; 71(7):541-8. PubMed ID: 16631217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of population characteristics related to the total effective xenoestrogen burden: a biomarker of xenoestrogen exposure in breast cancer.
    Fernandez MF; Santa-Marina L; Ibarluzea JM; Exposito J; Aurrekoetxea JJ; Torne P; Laguna J; Rueda AI; Pedraza V; Olea N
    Eur J Cancer; 2007 May; 43(8):1290-9. PubMed ID: 17466515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer].
    Bershtein LM; Kovalevskiĭ AIu; Poroshina TE; Revskoĭ SIu; Kotov AV; Kovalenko IG; Tsyrlina EV; Semiglazov VF; Turkevich EA; Pozharisskiĭ KM
    Vopr Onkol; 2008; 54(3):294-302. PubMed ID: 18652233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular links between obesity and breast cancer.
    Lorincz AM; Sukumar S
    Endocr Relat Cancer; 2006 Jun; 13(2):279-92. PubMed ID: 16728564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone, androgens and the mammary gland.
    Labrie F
    Gynecol Endocrinol; 2006 Mar; 22(3):118-30. PubMed ID: 16835073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.